359 related articles for article (PubMed ID: 29552692)
1. Causes of hyperhomocysteinemia and its pathological significance.
Kim J; Kim H; Roh H; Kwon Y
Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
[TBL] [Abstract][Full Text] [Related]
2. The Interaction between Arachidonic Acid Metabolism and Homocysteine.
Domi E; Hoxha M; Hoxha B; Zappacosta B
Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1232-1241. PubMed ID: 32888285
[TBL] [Abstract][Full Text] [Related]
3. [Hyperhomocysteinemia in neurologic diseases].
Siniscalchi A
Recenti Prog Med; 2004; 95(7-8):371-5; quiz 402. PubMed ID: 15303548
[TBL] [Abstract][Full Text] [Related]
4. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.
Sharma M; Tiwari M; Tiwari RK
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):287-96. PubMed ID: 26036286
[TBL] [Abstract][Full Text] [Related]
6. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
7. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
Kang SS; Rosenson RS
Cardiovasc Drugs Ther; 2018 Apr; 32(2):233-240. PubMed ID: 29679304
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk.
Ikkruthi S; Rajappa M; Nandeesha H; Satheesh S; Sundar I; Ananthanarayanan PH; Harichandrakumar KT
Acta Physiol Hung; 2014 Mar; 101(1):13-20. PubMed ID: 24311227
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine and Non-Cardiac Vascular Disease.
Katsiki N; Perez-Martinez P; Mikhailidis DP
Curr Pharm Des; 2017; 23(22):3224-3232. PubMed ID: 28317478
[TBL] [Abstract][Full Text] [Related]
11. [Hyperhomocysteinemia in patients with dementia].
Graban A
Neurol Neurochir Pol; 2003; 37(4):879-87. PubMed ID: 14746246
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies.
Zhou F; Chen S
Ageing Res Rev; 2019 May; 51():55-66. PubMed ID: 30826501
[TBL] [Abstract][Full Text] [Related]
13. Testing for homocysteine in clinical practice.
Nichols J
Nutr Health; 2017 Mar; 23(1):13-15. PubMed ID: 28068865
[TBL] [Abstract][Full Text] [Related]
14. The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan.
Shih CC; Shih YL; Chen JY
BMC Cardiovasc Disord; 2021 Apr; 21(1):191. PubMed ID: 33879044
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
Farina N; Jernerén F; Turner C; Hart K; Tabet N
Exp Gerontol; 2017 Dec; 99():146-150. PubMed ID: 29024723
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of homocysteine and its relationship with cardiovascular disease.
Aguilar B; Rojas JC; Collados MT
J Thromb Thrombolysis; 2004 Oct; 18(2):75-87. PubMed ID: 15789174
[TBL] [Abstract][Full Text] [Related]
18. Combined Effect of Hyperhomocysteinemia and Hypertension on the Presence of Early Carotid Artery Atherosclerosis.
Zhang Z; Fang X; Hua Y; Liu B; Ji X; Tang Z; Wang C; Guan S; Wu X; Liu H; Gu X
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1254-1262. PubMed ID: 26952151
[TBL] [Abstract][Full Text] [Related]
19. Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
Cheng X
Cardiovasc Ther; 2013 Aug; 31(4):e19-26. PubMed ID: 23082962
[TBL] [Abstract][Full Text] [Related]
20. [Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
Shakhmatova OO; Komarov AL; Panchenko EP
Kardiologiia; 2010; 50(1):42-50. PubMed ID: 20144157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
